These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1178688)

  • 21. Follow-up study of pauci-bacillary leprosy on-multi-drug regimen.
    Ramanan R; Manglani PR; Ghorpade A; Bhagoliwal SK
    Indian J Lepr; 1987; 59(1):50-3. PubMed ID: 3611861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphic acetylation of drugs in rabbits.
    Gordon GR; Shafizadeh AG; Peters JH
    Xenobiotica; 1973 Mar; 3(3):133-50. PubMed ID: 4729680
    [No Abstract]   [Full Text] [Related]  

  • 23. Parallel dapsone and rifampicin resistance: a prospective study.
    Sreevatsa ; Girdhar BK; Ramu G; Desikan KV
    Nihon Rai Gakkai Zasshi; 1984; 53(1):28-31. PubMed ID: 6469876
    [No Abstract]   [Full Text] [Related]  

  • 24. A study of drug interactions in leprosy--1. Effect of simultaneous administration of prothionamide on metabolic disposition of rifampicin and dapsone.
    Mathur A; Venkatesan K; Girdhar BK; Bharadwaj VP; Girdhar A; Bagga AK
    Lepr Rev; 1986 Mar; 57(1):33-7. PubMed ID: 3702578
    [No Abstract]   [Full Text] [Related]  

  • 25. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.
    Walker LL; Van Landingham RM; Shinnick TM
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy trial with a triple-drug regimen, including once-monthly Rimactane (Rifampicin), in patients with multibacillary types of leprosy.
    Reyes-Javier PD; Tantiongco PR
    Acta Leprol; 1983; 1(3):133-41. PubMed ID: 6359801
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacokinetics of aspirin and chloramphenicol in normal and leprotic patients before and after dapsone therapy.
    Garg SK; Kumar B; Shukla VK; Bakaya V; Lal R; Kaur S
    Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):204-5. PubMed ID: 3403099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug interactions -- the influence of rifampicin and clofazimine on the urinary excretion of DDS.
    Balakrishnan ; Seshadri PS
    Lepr India; 1981 Jan; 53(1):17-22. PubMed ID: 7218762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary drug resistance to both rifampicin and dapsone in a paucibacillary leprosy patient.
    Koranne RV; Srivastava G
    Indian J Lepr; 1988 Jan; 60(1):90-2. PubMed ID: 3060548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dapsone drug resistance in the MDT era.
    Roche PW; Neupane KD; Failbus SS; Butlin CR
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
    [No Abstract]   [Full Text] [Related]  

  • 32. Controlled comparison of therapeutic effects of DDS in combination with daily or once-monthly rifampicin in patients with lepromatous leprosy.
    Ghosh S; McDougall AC; Hazra SK; Yawalkar SJ
    Indian J Dermatol; 1981 Oct; 26(4):1-6. PubMed ID: 6754585
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of two multidrug regimen in hospitalised multibacillary cases.
    Chattopadhyay SP; Gupta CM; Bhate RD; Bhate RP; Sreevatsa
    Indian J Lepr; 1989 Apr; 61(2):196-205. PubMed ID: 2746028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of single dose (1500 mg) rifampicin on infectivity of patients with lepromatous leprosy.
    Girdhar BK; Sreevatsa ; Desikan KV
    Lepr India; 1980 Jul; 52(3):359-65. PubMed ID: 7206633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Problems of leprosy relapse in China.
    Li HY
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):1-7. PubMed ID: 8326169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
    Mendis S; Somasiri KG; Chularatna W
    Ceylon Med J; 1993 Dec; 38(4):174-7. PubMed ID: 8143332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dapsone inhibition of the bactericidal action of rifampicin on Mycobacterium leprae in mice].
    Millan J; Moulia-Pelat JP
    Med Trop (Mars); 1989; 49(4):337-41. PubMed ID: 2695734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lepromatous leprosy.
    Johnston SM; Ryan TJ
    Proc R Soc Med; 1973 Feb; 66(2):181-2. PubMed ID: 4714658
    [No Abstract]   [Full Text] [Related]  

  • 39. Multidrug therapy for paucibacillary leprosy: experience in Bombay.
    Revankar CR; Ganapati R; Naik DD
    Indian J Lepr; 1985; 57(4):773-9. PubMed ID: 3835208
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of acetylator phenotype of the leprosy patient on the emergence of dapsone resistant leprosy.
    Raj PP; Aschhoff M; Lilly L; Balakrishnan S
    Indian J Lepr; 1988 Jul; 60(3):400-6. PubMed ID: 3058828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.